American Century Companies Portfolio holdings
American Century Companies, Inc., founded in 1958 by James E. Stowers Jr. as Twentieth Century Mutual Funds and headquartered in Kansas City, Missouri, is a privately held investment management firm renowned for its focus on delivering investment results to clients while supporting medical research. Starting with just $100,000 from 24 shareholders, it rebranded to American Century Investments in 1997 and now manages hundreds of billions in assets across mutual funds, ETFs, and institutional portfolios, emphasizing no-load funds and a client-centric approach. The firm’s unique ownership structure sees over 40% of its profits funneled to the Stowers Institute for Medical Research, which it majority-owns, funding groundbreaking biomedical research, while Nomura Holdings holds a significant minority stake. With a global presence in cities like New York, London, and Hong Kong, and a workforce of around 1,400, American Century blends financial expertise with a mission to improve lives through both wealth creation and scientific advancement.
Top Buys
| 1 |
Broadcom
AVGO
|
+$250M |
| 2 |
Workday
WDAY
|
+$183M |
| 3 |
Apple
AAPL
|
+$178M |
| 4 |
Eli Lilly
LLY
|
+$172M |
| 5 |
GE Vernova
GEV
|
+$159M |
Top Sells
| 1 |
Visa
V
|
+$494M |
| 2 |
Colgate-Palmolive
CL
|
+$234M |
| 3 |
NXP Semiconductors
NXPI
|
+$184M |
| 4 |
Duke Energy
DUK
|
+$176M |
| 5 |
Intuitive Surgical
ISRG
|
+$166M |
Sector Composition
| 1 | Technology | 26.52% |
| 2 | Financials | 13.4% |
| 3 | Consumer Discretionary | 11.51% |
| 4 | Healthcare | 11.16% |
| 5 | Industrials | 10.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2751
PetMed Express
PETS
$57.8M
| $107K | ﹤0.01% |
29,203
+2,973
| +11% | +$10.9K |
|
2752
Zegna
ZGN
$2.22B
| $107K | ﹤0.01% |
10,840
| – | – |
|
2753
Sera Prognostics
SERA
$118M
| $104K | ﹤0.01% |
13,381
-12,301
| -48% | -$95.9K |
|
2754
Century Casinos
CNTY
$76.3M
| $103K | ﹤0.01% |
40,387
| – | – |
|
2755
Relmada Therapeutics
RLMD
$52.8M
| $102K | ﹤0.01% |
31,554
-64
| -0.2% | -$207 |
|
2756
Oportun Financial
OPRT
$293M
| $102K | ﹤0.01% |
36,181
-980
| -3% | -$2.75K |
|
|
PSTX
2757
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| $100K | ﹤0.01% |
35,074
-55,413
| -61% | -$158K |
|
2758
inTEST
INTT
$90.8M
| $99.1K | ﹤0.01% |
13,581
-1,092
| -7% | -$7.97K |
|
2759
Corvus Pharmaceuticals
CRVS
$434M
| $96.1K | ﹤0.01% |
18,208
-40
| -0.2% | -$211 |
|
2760
VistaGen Therapeutics
VTGN
$104M
| $90.9K | ﹤0.01% |
30,197
-118
| -0.4% | -$355 |
|
2761
Red Cat Holdings
RCAT
$1.1B
| $88.9K | ﹤0.01% |
+34,982
| New | +$88.9K |
|
2762
Werewolf Therapeutics
HOWL
$65.4M
| $87.8K | ﹤0.01% |
41,413
+3,779
| +10% | +$8.01K |
|
2763
Adverum Biotechnologies
ADVM
$63.4M
| $83.6K | ﹤0.01% |
+11,915
| New | +$83.6K |
|
|
BLDP
2764
Ballard Power Systems
BLDP
$622M
| $80.6K | ﹤0.01% |
44,869
+1,064
| +2% | +$1.91K |
|
2765
Expensify
EXFY
$178M
| $79.7K | ﹤0.01% |
+40,687
| New | +$79.7K |
|
2766
Generation Bio
GBIO
$39.9M
| $77.4K | ﹤0.01% |
3,132
-47
| -1% | -$1.16K |
|
2767
Paysign
PAYS
$301M
| $75.4K | ﹤0.01% |
20,558
-820
| -4% | -$3.01K |
|
2768
Lifecore Biomedical
LFCR
$281M
| $71.4K | ﹤0.01% |
14,481
-17,501
| -55% | -$86.3K |
|
|
CLYM
2769
Climb Bio, Inc. Common Stock
CLYM
$152M
| $70.7K | ﹤0.01% |
+13,885
| New | +$70.7K |
|
2770
Amylyx Pharmaceuticals
AMLX
$1.24B
| $68.2K | ﹤0.01% |
21,049
+2,008
| +11% | +$6.51K |
|
|
VIGL
2771
DELISTED
Vigil Neuroscience
VIGL
| $67.9K | ﹤0.01% |
+19,970
| New | +$67.9K |
|
|
LAR
2772
Lithium Argentina AG
LAR
$490M
| $62.9K | ﹤0.01% |
19,212
+532
| +3% | +$1.74K |
|
|
AEVA
2773
Aeva Technologies
AEVA
$903M
| $62.7K | ﹤0.01% |
19,049
+3,785
| +25% | +$12.5K |
|
|
SEG.RT
2774
DELISTED
Seaport Entertainment Group Inc. Rights (expiring October 10, 2024)
SEG.RT
| $61.6K | ﹤0.01% |
+20,892
| New | +$61.6K |
|
|
QIPT
2775
Quipt Home Medical
QIPT
$117M
| $61.4K | ﹤0.01% |
+21,136
| New | +$61.4K |
|